News · 26 weeks380%
2026-03-012026-08-23
Mix2290d
- Other9(41%)
- SEC Filings6(27%)
- Earnings4(18%)
- Insider3(14%)
Latest news
25 items- PRPETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATIONNew Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal Health MINNEAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) ("PetVivo" or the "Company"), an emerging biomedical device company focused on the commercialization and development of innovative medical devices and therapeutics, announced today that its subsidiary, Cosmeta Corp., has changed its name to Somatrix Technologies, Inc. ("Somatrix"). The new name reflects the Company's strategic vision for Somatrix as a dedicated human health subsidiary focused on the research and development of innovative biomaterial technologies wi
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- SECSEC Form 10-Q filed by PetVivo Holdings Inc.10-Q - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026. PetVivo will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer period (see dial-in information below). Fiscal Q1 2027 Operational Highlights Announced the acquisition of PiezoBioMembrane (P
- PRPetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Aug. 07, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)), an emerging biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, August 14, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2026. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal First Quarter 2027 conference call information is as follows: Date: Friday, August 14, 2026Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time
- SECSEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.SCHEDULE 13G - PetVivo Holdings, Inc. (0001512922) (Subject)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEMAgreement Resolves All Outstanding Matters and Completes Transition of PrecisePRP® Product Line MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)) working in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc. (collectively "PetVivo" or the "Company"), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for horses and companion animals, today announced that it has entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24, 2026. Under the agreement, the parties have terminated their Exclus
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 75,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- PRPetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary RecordPeer-Reviewed Study Demonstrates Feasibility and Statistically Significant Improvements in Subjective Clinical Outcomes in Dogs with Stifle Osteoarthritis and Suspected Cranial Cruciate Disease Minneapolis, MN, July 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced the publication of a peer-reviewed clinical study evaluating Spryng® with OsteoCushion® Technology in the peer-reviewed journal Veterinary Record. The publication repre
- SECSEC Form 10-K filed by PetVivo Holdings Inc.10-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo Reports Financial and Operational Results for Fiscal 2026MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported operational results for the fourth quarter of its fiscal year ended March 31, 2026, and financial results for the full fiscal year. PetVivo will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer session (see dial-in information below). Fiscal Q4 Operational Highlights
- PRLife Sciences Virtual Investor Forum Presentations Now Available for On-Demand ViewingNEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19th. Please Schedule 1x1 Meetings here. The presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Presenting Companies CompanyTicker(s)MetaVia Inc.(NASDAQ:MTVA)Nasus Pharma Ltd.(NYSE:NSRX)CytoSorbents Corporation(NASD
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, will report financial results for the year ending March 31, 2026, on Monday, June 29, 2026 after market close. The company will host a conference call to discuss these results at 5:00 p.m. CT (6:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo’s Investor
- PRPetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials PlatformAcquisition Strengthens Company's Intellectual Property Portfolio and Creates New Opportunities for Medical Device and Therapeutic Product Development Across Animal and Human Health Markets MINNEAPOLIS, MN, US, June 24, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced that it has entered into an Agreement and Plan of Merger to acquire PiezoBioMembrane, Inc. ("PBM"), a developer of advanced functional biomaterials and piezoelectric te
- PRLife Sciences Virtual Investor Forum Agenda Announced for June 24th & 25thNEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings
- PRPetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24thMINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced that John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 24th, 2026 DATE: June 24th TIME: 12:00pm ET REGISTER HERE Available for 1x1 meetings: June 24, 2026, through June 30, 2026. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online
- PRPetVivo Holdings, Inc. to Host Virtual Investor EventVirtual investor event scheduled for Tuesday, June 16, 2026, at 1 p.m. ET MINNEAPOLIS, MN, US, June 08, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, announced today that it will host a virtual investor event titled "What Veterinarians Are Seeing and How Access Is Expanding" on Tuesday, June 16 at 1 p.m. ET. The event is designed for both new and current investors and will provide an overview of the Company's business, including discussion around Spryng® with
- INSIDERLarge owner A.L. Sarroff Fund, Llc gifted 200,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERLarge owner A.L. Sarroff Fund, Llc bought $100,000 worth of shares (250,000 units at $0.40) (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 66,421 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 66,421 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
PETV FAQ
6 questionsWhat does PetVivo Holdings Inc. do?
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.Where does PETV stock trade?
PetVivo Holdings Inc. (PETV) is listed on NASDAQ.What sector and industry is PETV in?
PetVivo Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about PETV?
PetVivo Holdings Inc. has had 1 recent analyst action on file. The most recent action was from ThinkEquity: Buy with a $700.00 price target on 2021-10-12. Recent price targets cluster around $700.00.What companies are similar to PETV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare PETV side-by-side with any of them on Quantisnow.How can I track PETV on Quantisnow?
Quantisnow aggregates PetVivo Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETV to receive live email and push alerts on every new disclosure.